Clinical trials on broadly neutralising antibodies crucial for HIV prevention - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.
Clinical trials examining broadly neutralising antibodies could hold critical information to protect high-risk communities from HIV. The trials are currently underway in Durban at the Centre for the Aids Programme of Research in South Africa (CAPRISA).